Home > Boards > US Listed > Medical - Equipment > Cytosorbents Corporation (CTSO)

That is impossible to track, either way. There

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
biotech48 Member Profile
 
Followed By 2
Posts 581
Boards Moderated 0
Alias Born 03/22/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/24/2022 4:31:32 PM
New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology PR Newswire (US) - 1/24/2022 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2022 4:32:05 PM
Leerink Partners Thinks Cytosorbents’ Stock is Going to Recover TipRanks - 1/20/2022 3:46:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/18/2022 4:32:30 PM
CytoSorbents jumps 1.86% on prelim FY21 and Q4 revenue above the consensus Seeking Alpha - 1/18/2022 7:35:44 AM
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue PR Newswire (US) - 1/18/2022 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2022 5:11:35 PM
Dawson James Remains a Buy on Cytosorbents (CTSO) TipRanks - 1/5/2022 4:10:04 AM
Dawson James Sticks to Their Buy Rating for Cytosorbents (CTSO) TipRanks - 1/5/2022 4:08:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/30/2021 5:29:04 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/30/2021 5:27:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2021 9:01:13 AM
CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular PR Newswire (US) - 12/21/2021 7:05:00 AM
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) PR Newswire (US) - 12/20/2021 7:10:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/13/2021 5:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2021 9:06:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/26/2021 6:11:44 PM
CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference PR Newswire (US) - 11/15/2021 4:30:00 PM
Cytosorbents EPS misses by $0.03, beats on revenue Seeking Alpha - 11/4/2021 4:29:11 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2021 4:15:41 PM
CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results PR Newswire (US) - 11/4/2021 4:15:00 PM
Cytosorbents Q3 2021 Earnings Preview Seeking Alpha - 11/3/2021 5:35:41 PM
CytoSorbents Comments on REMOVE Study Presentation PR Newswire (US) - 10/20/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2021 6:26:17 AM
biotech48   Saturday, 12/09/17 12:06:45 PM
Re: coldterdinvestor post# 10465
Post # of 27014 
That is impossible to track, either way. There are many dynamics occurring at once. On the other hand, his meetings could bear fruit weeks or months later. It is doubtful that someone leaves a meeting and invests in the company the same day. coldterinvestor they then do something called due diligence before they invest. Have you heard of that?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences